The Impact Proteomics team is thrilled to announce that Dr. Frederick Strathmann has joined our Board of Directors. Dr. Strathmann has been in laboratory medicine for over 15 years and has held previous positions including Assistant Professor of Pathology & Laboratory Medicine, Medical Director of Toxicology, Scientific Director of Mass Spectrometry, and Senior Vice President of Operations and R&D. He has worked in hospital and national reference laboratory environments, is board certified by the American Board of Clinical Chemistry in both Clinical Chemistry and Toxicological Chemistry and serves as a part-time CLIA Laboratory Director for High Complexity Testing for Smithers Pharmaceutical Development Services at their New Jersey and Maryland locations. He completed his MS and PhD in Pathology & Laboratory Medicine and a postdoctoral fellowship in Biomedical Genetics from the University of Rochester School of Medicine and Dentistry in Rochester, New York, a Clinical Fellowship at the University of Washington in Seattle, Washington, and an MBA from the University of Utah in Salt Lake City, Utah. In his current role with MOBILion Systems, Dr. Strathmann is the Senior Vice President for the Global Business and is responsible for all business related to product launch and strategy development in the Biopharma, Applied and Clinical markets.